YECO OTC
EV Biologics, Inc.
1W: +0.0%
1M: -75.0%
3M: -50.0%
YTD: -99.9%
1Y: -99.9%
3Y: -100.0%
5Y: -99.9%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000099999997-0.1056
Volume10,000
Avg Volume1,968
Beta0.45
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEODaniel S. McKinney
Employees284
SectorHealthcare
IndustryBiotechnology
IPO Date2015-06-29
Websiteevbiologics.com
1621 Central Avenue
Cheyenne, WY 82001
US
Cheyenne, WY 82001
US
206-734-4738
About EV Biologics, Inc.
EV Biologics, Inc. is a biotechnology enterprise focused on the commercial advancement of extracellular vesicles (EVs), utilizing them as biological agents for diagnostic and therapeutic applications. The company capitalizes on its proprietary, versatile EV platform to engineer innovative vaccines, treatments, and potential cures. Beyond EVs, it also dedicates efforts to cultivating human mesenchymal and other stem cells, as well as various cell-derived products, to address the needs of the cosmetic and biopharmaceutical industries. Founded in 2011, the firm was originally known as Yulong Eco-Materials Limited until its rebranding to EV Biologics, Inc. in August 2020, and it operates from its headquarters in Cheyenne, Wyoming.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| McKinney Daniel S | J-Other | 25,000,000 | — | 2019-01-31 |
| McKinney Daniel S | J-Other | 900 | $1.34 | 2018-12-18 |
| McKinney Daniel S | J-Other | 200 | $5.99 | 2018-11-27 |
| McKinney Daniel S | J-Other | 300 | $5.07 | 2018-11-16 |
| McKinney Daniel S | J-Other | 200 | $6.09 | 2018-11-08 |